Activist investor Starboard Value says it will oppose Bristol-Myers' deal for Celgene
February 28, 2019 at 09:54 AM EST
The activist investor said Thursday that it intends to use its stake in Bristol-Myers Squibb to oppose its acquisition of Celgene.
